Lilly and Novo Are Reportedly Near a Deal, Offering $149 GLP-1s in Return for Coverage in Medicare

A quick note: The number of folks who opened Cost Curve yesterday fell precipitously. I’m not worried about the statistics, but I do suspect that the experimentation with the easier-to-read

So I managed to screw up at least two things yesterday. First off, I misspelled Leana Wen’s name. Second, I included the wrong link in discussing Wen’s op-ed. The right

Well, this is a fitting end to a wild week. We now have the 15 medicines that will go through the next round of price-setting “negotiations” with CMS. Here are